Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial
Catherine Chiron(Inserm), Gérard Pons(Université Paris Cité), Olivier Dulac(Oglala Lakota College), Elisabeth Rey(Université Paris Cité), P D’Athis, Jean‐Louis Vincent(Université Libre de Bruxelles), A. Tran(Université Paris Cité), M.C. Marchand(Hôpital Saint-Vincent-de-Paul)
Cited by 565
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure
|Intensive Care Medicine|1996|11.7k
Surviving Sepsis Campaign
|Critical Care Medicine|2013|9.7k
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
|Intensive Care Medicine|2013|7.3k
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
|New England Journal of Medicine|2001|6.1k